Last updated: 15:40
No Notes Added Yet
Neochem Bio Solutions Ltd. is an Indian speciality performance chemical manufacturer with a history dating back to 2006. The company produces a broad portfolio of over 350 customised chemical formulations across key segments such as polymers, surfactants, silicones, and esters including bio-based sustainable solutions, which are used as essential inputs in a wide range of industries like textile and garment processing, home and personal care products, industrial and institutional cleaners, water treatment, paints and coatings, construction, pap...Read More
Neochem Bio Solutions Ltd. is an Indian speciality performance chemical manufacturer with a history dating back to 2006. The company produces a broad portfolio of over 350 customised chemical formulations across key segments such as polymers, surfactants, silicones, and esters including bio-based sustainable solutions, which are used as essential inputs in a wide range of industries like textile and garment processing, home and personal care products, industrial and institutional cleaners, water treatment, paints and coatings, construction, paper and pulp, rubber, and dyes and pigments. Its manufacturing operations are centred at a facility in Moraiya (Sanand), Ahmedabad, with an installed capacity of around 22,000 metric tonnes per annum, and the company serves a network of authorised distributors and hundreds of domestic and international customers. In December 2025, Neochem Bio Solutions completed a successful SME initial public offering (IPO) on the NSE Emerge platform, which was highly subscribed and saw its shares list at a premium, reflecting strong market interest as it uses the IPO proceeds to support working capital, debt repayment, and corporate growth initiatives. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹130 Cr.
Stock P/E 16.8
P/B 3.5
Current Price ₹76
Book Value ₹ 21.4
Face Value 10
52W High ₹113.4
Dividend Yield 0%
52W Low ₹ 63
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Net Sales | 48 | 61 | 84 | |
| Other Income | 1 | 1 | 2 | |
| Total Income | 49 | 62 | 86 | |
| Total Expenditure | 44 | 55 | 71 | |
| Operating Profit | 5 | 7 | 15 | |
| Interest | 2 | 3 | 4 | |
| Depreciation | 1 | 1 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | |
| Profit Before Tax | 2 | 3 | 10 | |
| Provision for Tax | 0 | 1 | 3 | |
| Profit After Tax | 1 | 2 | 8 | |
| Adjustments | 0 | 0 | 0 | |
| Profit After Adjustments | 1 | 2 | 8 | |
| Adjusted Earnings Per Share | 1.1 | 1.5 | 6.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 38% | 0% | 0% | 0% |
| Operating Profit CAGR | 114% | 0% | 0% | 0% |
| PAT CAGR | 300% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 49% | 27% | 27% | 27% |
| ROCE Average | 27% | 17% | 17% | 17% |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Shareholder's Funds | 8 | 12 | 20 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 12 | 18 | 14 |
| Other Non-Current Liabilities | 1 | 1 | 1 |
| Total Current Liabilities | 29 | 33 | 44 |
| Total Liabilities | 51 | 64 | 79 |
| Fixed Assets | 15 | 19 | 19 |
| Other Non-Current Assets | 4 | 7 | 7 |
| Total Current Assets | 32 | 39 | 53 |
| Total Assets | 51 | 64 | 79 |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -1 | 2 | 3 |
| Cash Flow from Investing Activities | -3 | -8 | -2 |
| Cash Flow from Financing Activities | 4 | 6 | -1 |
| Net Cash Inflow / Outflow | -0 | 0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 |
| # | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Earnings Per Share (Rs) | 1.13 | 1.54 | 6.64 |
| CEPS(Rs) | 2.41 | 2.59 | 7.77 |
| DPS(Rs) | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 8.48 | 10.27 | 16.91 |
| Core EBITDA Margin(%) | 8.77 | 9.8 | 15.58 |
| EBIT Margin(%) | 7.5 | 9.21 | 16.35 |
| Pre Tax Margin(%) | 3.15 | 4.37 | 12.19 |
| PAT Margin (%) | 2.23 | 2.95 | 9.21 |
| Cash Profit Margin (%) | 4.75 | 4.94 | 10.79 |
| ROA(%) | 2.12 | 3.14 | 10.84 |
| ROE(%) | 13.33 | 17.96 | 48.82 |
| ROCE(%) | 10.54 | 14.15 | 27.34 |
| Receivable days | 109.19 | 94.48 | 92.18 |
| Inventory Days | 113.09 | 98.91 | 90.99 |
| Payable days | 156.95 | 130.08 | 100.44 |
| PER(x) | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.66 | 0.65 | 0.5 |
| EV/Core EBITDA(x) | 6.55 | 5.79 | 2.8 |
| Net Sales Growth(%) | 0 | 26.89 | 37.66 |
| EBIT Growth(%) | 0 | 55.86 | 144.44 |
| PAT Growth(%) | 0 | 67.89 | 330.28 |
| EPS Growth(%) | 0 | 36.48 | 330.28 |
| Debt/Equity(x) | 3.26 | 2.78 | 1.8 |
| Current Ratio(x) | 1.09 | 1.17 | 1.21 |
| Quick Ratio(x) | 0.58 | 0.62 | 0.67 |
| Interest Cover(x) | 1.72 | 1.9 | 3.93 |
| Total Debt/Mcap(x) | 0 | 0 | 0 |
| # | Mar 2026 |
|---|---|
| Promoter | 66.72 |
| FII | 0.18 |
| DII | 15.82 |
| Public | 17.28 |
| Others | 0 |
| Total | 100 |
| # | Mar 2026 |
|---|---|
| Promoter | 1.14 |
| FII | 0 |
| DII | 0.27 |
| Public | 0.3 |
| Others | 0 |
| Total | 1.71 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
